Cisplatin, Adriamycin, Etoposide, Megestrol Acetate versus Melphalan, 5-Fluorouracil, Medroxyprogesterone Acetate in the Treatment of Endometrial Carcinoma

By Cornelison T.L.   Baker T.R.   Piver S.M.   Driscoll D.L.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 243-248

Academic Press

Access to resources Recommend Favorite

Endometrial Carcinoma Remaining after Term Pregnancy Following Conservative Treatment with Medroxyprogesterone Acetate

By Mitsushita J.   Toki T.   Kato K.   Fujii S.   Konishi I.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Expression Is Not Regulated by Estradiol or Medroxyprogesterone Acetate in Endometrial Carcinoma

By Kim Y.B.   Berek J.S.   Martinez-Maza O.   Satyaswaroop P.G.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 97-100

Academic Press

Access to resources Recommend Favorite

The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia

By Abulafia O.   Triest W.E.   Adcock J.T.   Sherer D.M.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

Fertility-Sparing Surgery in Uterine Leiomyosarcoma

By Lissoni A.   Cormio G.   Bonazzi C.   Perego P.   Lomonico S.   Gabriele A.   Bratina G.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 348-350

Elsevier

Access to resources Recommend Favorite